The invention relates to pharmaceutical compositions containing at least one 5- (benz- (Z) -ylidene-thiazolidin-4-one derivative (I), to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
这项发明涉及含有至少一种5-(苯基(Z)-基
噻唑烷酮衍
生物(I)的药物组合物,用于预防或治疗与激活的免疫系统相关的疾病。此外,该发明涉及新型
噻唑烷酮衍
生物,特别用作药用活性化合物。这些化合物特别还作为
免疫抑制剂起作用。